Long Non-Coding RNA 554 Promotes Cardiac Fibrosis via TGF-β1 Pathway in Mice Following Myocardial Infarction

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• RNA Biology

Background:

• Cardiac fibrosis is a hallmark of myocardial disease, contributing to impaired heart function.
• Long non-coding RNAs (lncRNAs) are implicated in cardiac fibrosis, but their specific roles and mechanisms are not fully understood.

Purpose of the Study:

• To characterize the expression and function of lncRNA 554 in cardiac fibroblasts (CFs) post-myocardial infarction (MI).
• To investigate the contribution of lncRNA 554 to cardiac fibrosis and cardiac function.

Main Methods:

• Identification of lncRNA 554 expression in mouse hearts after MI.
• In vitro studies using siRNA to knockdown lncRNA 554 in CFs.
• In vivo studies using lentivirus-mediated knockdown of lncRNA 554 in a mouse MI model.
• Assessment of extracellular matrix (ECM) gene expression and cardiac function.

Main Results:

• lncRNA 554 was significantly upregulated in mouse hearts following MI and predominantly expressed in CFs.
• Knockdown of lncRNA 554 suppressed fibroblast migration and ECM production, while overexpression promoted ECM gene expression.
• In vivo knockdown of lncRNA 554 inhibited cardiac fibrosis and improved cardiac function in MI mice.
• The pro-fibrotic effects of lncRNA 554 were dependent on TGF-β1 signaling.

Conclusions:

• lncRNA 554 acts as a regulator of MI-induced cardiac fibrosis.
• lncRNA 554 promotes cardiac fibrosis through TGF-β1 dependent pathways.
• lncRNA 554 represents a potential novel therapeutic target for treating cardiac fibrosis.